Causal Effect of Low-Density Lipoprotein Cholesterol on Chronic Kidney Disease: A Mendelian Randomization Study. [PDF]
Zhou D, Zheng K, Zhang S, Zheng B.
europepmc +1 more source
Beyond PEGylation: Archaeal Lipids for Long‐Circulating Liposomes
Archaeal lipid‐based liposomes, particularly those containing caldarchaeol (GDGT), were found to significantly prolong the circulation time of vancomycin in rats, matching the pharmacokinetic properties of PEGylated systems. These findings suggest archaeal lipids as promising non‐PEG excipients for parenteral applications to minimize drug clearance ...
Viktor Sedlmayr +9 more
wiley +1 more source
Friedewald and Martin-Hopkins formulae for estimating low-density lipoprotein cholesterol in a Malagasy population. [PDF]
Rakotonjafiniarivo FH +4 more
europepmc +1 more source
We developed an assay to distinguish cellular binding from internalization. Compatible with microscopy and high‐throughput screening, the method identifies ligand‐mediated uptake. Applying top candidates to a protein‐based DNA carrier enhanced transfection efficiency, providing a rational strategy to improve non‐viral gene delivery systems.
David Scherer +5 more
wiley +1 more source
Lipoprotein X: A Cause for Misleading Levels of Low-Density Lipoprotein. [PDF]
Lee R +4 more
europepmc +1 more source
Estimated small dense low-density lipoprotein cholesterol and hyperuricemia in diabetic patients. [PDF]
Xu M +5 more
europepmc +1 more source
Oxidized low-density lipoprotein cholesterol and plaque vulnerability. [PDF]
Goto J +11 more
europepmc +1 more source
Does Pemafibrate Lower Low-Density Lipoprotein-Cholesterol? [PDF]
Fujioka Y.
europepmc +1 more source
Effects of Ubiquinol on Oxidized Low-Density Lipoprotein in Prediabetic Patients: A Randomized, Double-Blinded, Placebo-Controlled Study. [PDF]
Leaovitavat R +3 more
europepmc +1 more source

